Why This Stack Works
This protocol attacks fat loss through three complementary mechanisms:
-
Semaglutide (a GLP-1 receptor agonist) dramatically reduces appetite and improves insulin sensitivity. Clinical trials demonstrate average weight loss of 15-20% of body weight over 68 weeks.
-
CJC-1295 provides sustained GHRH signaling that elevates baseline growth hormone levels. This enhances lipolysis (fat breakdown) and supports metabolic rate during a caloric deficit.
-
Ipamorelin triggers clean, pulsatile GH release that specifically targets fat metabolism while preserving lean muscle mass — the biggest challenge in any weight loss program.
The combination ensures you lose fat, not muscle, while experiencing dramatically reduced hunger.
Who This Protocol Is For
- Individuals with significant weight to lose (20+ lbs) who have struggled with diet alone
- Those seeking medically-supervised weight loss with peptide support
- People who want to preserve muscle mass during aggressive fat loss
- Anyone with insulin resistance or metabolic syndrome looking for pharmaceutical support
Semaglutide Titration Schedule
| Weeks | Dose | Notes |
|---|---|---|
| 1-4 | 0.25mg/week | Initiation phase — allows GI adaptation |
| 5-8 | 0.5mg/week | Most users begin noticing significant appetite reduction |
| 9-12 | 1.0mg/week | Increase only if tolerated and weight loss has plateaued |
| 13-16+ | 1.5-2.0mg/week | Maximum therapeutic dose; not all users need this |
Critical: Do not rush titration. Nausea, vomiting, and diarrhea are dose-dependent and typically manageable with slow titration.
Managing Semaglutide Side Effects
The most common side effects are gastrointestinal:
- Nausea: Eat smaller, more frequent meals. Avoid high-fat foods. Ginger or ondansetron can help.
- Constipation: Increase fiber and water intake. Magnesium citrate (400mg) at bedtime can help.
- Reduced appetite: While this is the goal, ensure you still hit minimum protein targets. Protein shakes can help on low-appetite days.
- Injection site reactions: Rotate injection sites. Mild redness typically resolves within 24 hours.
GH Peptide Timing Is Critical
Both CJC-1295 and Ipamorelin effectiveness depends on timing:
- Fasted state: GH release is blunted by insulin. Always administer on an empty stomach.
- Before bed: Nocturnal GH pulses are the largest natural pulses. Peptide dosing before sleep amplifies this window.
- No carbs or food for 2 hours post-injection: Eating after injection will blunt the GH response.
Expected Results Timeline
- Weeks 1-4: Gradual appetite reduction from Semaglutide. Initial GH optimization from peptides. Weight loss of 2-4 lbs.
- Weeks 5-8: Significant appetite suppression. Improved energy and sleep from GH peptides. Weight loss accelerates to 1-2 lbs/week.
- Weeks 9-12: Full stack synergy. Noticeable improvements in body composition — fat loss with muscle preservation. Cumulative weight loss of 10-20 lbs.
- Weeks 13-16: Continued fat loss, especially visceral fat. Many users report significant improvements in metabolic markers (fasting glucose, triglycerides).
Safety Notes
- Semaglutide is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome.
- Report severe or persistent GI symptoms to your prescribing physician.
- CJC-1295 and Ipamorelin may cause water retention, tingling, or mild hunger. These are typically transient.
- Monitor thyroid function, as GLP-1 agonists may affect thyroid markers in rare cases.
- This protocol should be supervised by a licensed healthcare provider.
- Store all reconstituted peptides in the refrigerator and use within 30 days.